{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:09:22Z","timestamp":1793340562250,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2024R386"],"award-info":[{"award-number":["PNURSP2024R386"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02603-w","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:19:41Z","timestamp":1737523181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy"],"prefix":"10.1007","volume":"42","author":[{"given":"Hanan","family":"Alyami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitah","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Jaber","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ebrahimi Shahmabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"3","key":"2603_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2603_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167\u201392. https:\/\/doi.org\/10.6004\/jnccn.2022.0008.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"2603_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/0885328219837683","volume":"33","author":"J Cai","year":"2019","unstructured":"Cai J, Qian K, Zuo X, Yue W, Bian Y, Yang J, et al. PLGA nanoparticle-based docetaxel\/LY294002 drug delivery system enhances antitumor activities against gastric cancer. J Biomater Appl. 2019;33(10):1394\u2013406. https:\/\/doi.org\/10.1177\/0885328219837683.","journal-title":"J Biomater Appl"},{"issue":"4","key":"2603_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778\u201389. https:\/\/doi.org\/10.1002\/ijc.33588.","journal-title":"Int J Cancer"},{"issue":"1","key":"2603_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22(1):704. https:\/\/doi.org\/10.1186\/s12967-024-05498-9.","journal-title":"J Transl Med"},{"key":"2603_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S149619","author":"R Sitarz","year":"2018","unstructured":"Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018. https:\/\/doi.org\/10.2147\/CMAR.S149619.","journal-title":"Cancer Manag Res."},{"issue":"27","key":"2603_CR7","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1021\/acsami.3c03528","volume":"15","author":"H Afrin","year":"2023","unstructured":"Afrin H, Esquivel SV, Kumar R, Zahid MI, Oporeza B, Rahman MF, et al. \u03b2-glucan-mediated oral codelivery of 5FU and Bcl2 siRNA attenuates stomach cancer. ACS Appl Mater Interfaces. 2023;15(27):32188\u2013200. https:\/\/doi.org\/10.1021\/acsami.3c03528.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"2603_CR8","doi-asserted-by":"publisher","first-page":"18285","DOI":"10.1021\/acsami.3c15976","volume":"16","author":"H-L Huang","year":"2024","unstructured":"Huang H-L, Chen K-W, Liao H-W, Wang L-Y, Peng S-L, Lai C-H, et al. Nanoparticles for augmenting therapeutic potential and alleviating the effect of Di (2-ethylhexyl) phthalate on gastric cancer. ACS Appl Mater Interfaces. 2024;16(15):18285\u201399. https:\/\/doi.org\/10.1021\/acsami.3c15976.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2603_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-06869-3","volume":"20","author":"E Gu","year":"2020","unstructured":"Gu E, Song W, Liu A, Wang H. SCDb: an integrated database of stomach cancer. BMC Cancer. 2020;20:1\u201310. https:\/\/doi.org\/10.1186\/s12885-020-06869-3.","journal-title":"BMC Cancer"},{"issue":"13","key":"2603_CR10","first-page":"1191","volume":"1","author":"KA Hotchkiss","year":"2002","unstructured":"Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther. 2002;1(13):1191\u2013200.","journal-title":"Mol Cancer Ther"},{"key":"2603_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ijbiomac.2018.12.262","volume":"126","author":"E Zhang","year":"2019","unstructured":"Zhang E, Xing R, Liu S, Li K, Qin Y, Yu H, et al. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy. Int J Biol Macromol. 2019;126:662\u201372. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.12.262.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"2603_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3892\/or_00000689","volume":"23","author":"D Zheng","year":"2010","unstructured":"Zheng D, Li D, Lu X, Feng Z. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery. Oncol Rep. 2010;23(3):717\u201324. https:\/\/doi.org\/10.3892\/or_00000689.","journal-title":"Oncol Rep"},{"issue":"2","key":"2603_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/CAD.0b013e3280113338","volume":"18","author":"FK Engels","year":"2007","unstructured":"Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs. 2007;18(2):95\u2013103. https:\/\/doi.org\/10.1097\/CAD.0b013e3280113338.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"2603_CR14","doi-asserted-by":"publisher","first-page":"103849","DOI":"10.1016\/j.drudis.2023.103849","volume":"29","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alharthi S, Alavi SZ, Raza A, Shahmabadi HE. Bioresponsive drug delivery systems. Drug Discov Today. 2024;29(1):103849. https:\/\/doi.org\/10.1016\/j.drudis.2023.103849.","journal-title":"Drug Discov Today"},{"issue":"4","key":"2603_CR15","doi-asserted-by":"publisher","first-page":"103936","DOI":"10.1016\/j.drudis.2024.103936","volume":"29","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alharthi S, Alavi SF, Alavi SZ, Zahra GE, Raza A, et al. Microfluidics for personalized drug delivery. Drug Discov Today. 2024;29(4):103936. https:\/\/doi.org\/10.1016\/j.drudis.2024.103936.","journal-title":"Drug Discov Today"},{"issue":"7","key":"2603_CR16","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acs.bioconjchem.0c00291","volume":"31","author":"SE Alavi","year":"2020","unstructured":"Alavi SE, Cabot PJ, Yap GY, Moyle PM. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne\u2013azide cycloaddition. Bioconjug Chem. 2020;31(7):1820\u201334. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00291.","journal-title":"Bioconjug Chem"},{"issue":"6","key":"2603_CR17","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1021\/acs.molpharmaceut.9b00308","volume":"16","author":"SE Alavi","year":"2019","unstructured":"Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00308.","journal-title":"Mol Pharm"},{"issue":"8","key":"2603_CR18","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.drudis.2021.03.032","volume":"26","author":"SE Alavi","year":"2021","unstructured":"Alavi SE, Shahmabadi HE. GLP-1 peptide analogs for targeting pancreatic beta cells. Drug Discov Today. 2021;26(8):1936\u201343. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.032.","journal-title":"Drug Discov Today"},{"key":"2603_CR19","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.eurpolymj.2022.111652","volume":"181","author":"SE Alavi","year":"2022","unstructured":"Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, et al. Hydrogel-based therapeutic coatings for dental implants. Eur Polym J. 2022;181:111652. https:\/\/doi.org\/10.1016\/j.eurpolymj.2022.111652.","journal-title":"Eur Polym J"},{"issue":"3","key":"2603_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12291-013-0325-0","volume":"29","author":"H Ebrahimi Shahmabadi","year":"2014","unstructured":"Shahmabadi HE, Doun SKB, Alavi SE, Mortazavi M, Saffari Z, Farahnak M, et al. An investigation into the parameters affecting preparation of polybutyl cyanoacrylate nanoparticles by emulsion polymerization. Indian J Clin Biochem. 2014;29(3):357\u201361. https:\/\/doi.org\/10.1007\/s12291-013-0325-0.","journal-title":"Indian J Clin Biochem"},{"issue":"4","key":"2603_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1021\/acs.bioconjchem.1c00091","volume":"32","author":"SE Alavi","year":"2021","unstructured":"Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne\u2013azide cycloaddition and evaluation of their biological activity. Bioconjug Chem. 2021;32(4):810\u201320. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00091.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"2603_CR22","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/s41598-022-05793-9","volume":"12","author":"F Yaghoubi","year":"2022","unstructured":"Yaghoubi F, Motlagh NSH, Naghib SM, Haghiralsadat F, Jaliani HZ, Moradi A. A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment. Sci Rep. 2022;12(1):1959. https:\/\/doi.org\/10.1038\/s41598-022-05793-9.","journal-title":"Sci Rep"},{"key":"2603_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-024-00691-w","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alavi SF, Koohi M, Raza A, Ebrahimi H, Shahmabadi. Nanoparticle-integrated metal\u2013organic frameworks: a revolution in next-generation drug delivery systems. J Pharm Investig. 2024. https:\/\/doi.org\/10.1007\/s40005-024-00691-w.","journal-title":"J Pharm Investig"},{"key":"2603_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bioactmat.2024.03.003","volume":"36","author":"H Li","year":"2024","unstructured":"Li H, Wang S, Yang Z, Meng X, Niu M. Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors. Bioact Mater. 2024;36:376\u2013412. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.03.003.","journal-title":"Bioact Mater."},{"issue":"5","key":"2603_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ebiom.2015.05.013","volume":"2","author":"C He","year":"2015","unstructured":"He C, Chan C, Weichselbaum RR, Fleming GF, Yamada SD, Lin W. Nanomedicine for combination therapy of cancer. EBioMedicine. 2015;2(5):366\u20137. https:\/\/doi.org\/10.1016\/j.ebiom.2015.05.013.","journal-title":"EBioMedicine"},{"key":"2603_CR26","doi-asserted-by":"publisher","first-page":"111786","DOI":"10.1016\/j.colsurfb.2021.111786","volume":"204","author":"L Miao","year":"2021","unstructured":"Miao L, Daozhou L, Ying C, Qibing M, Siyuan Z. A resveratrol-loaded nanostructured lipid carrier hydrogel to enhance the anti-UV irradiation and anti-oxidant efficacy. Colloids Surf B Biointerfaces. 2021;204:111786. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111786.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2603_CR27","doi-asserted-by":"publisher","first-page":"118771","DOI":"10.1016\/j.ijpharm.2019.118771","volume":"572","author":"P Lakhani","year":"2019","unstructured":"Lakhani P, Patil A, Wu K-W, Sweeney C, Tripathi S, Avula B, et al. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572:118771. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118771.","journal-title":"Int J Pharm"},{"key":"2603_CR28","doi-asserted-by":"publisher","first-page":"120363","DOI":"10.1016\/j.ijpharm.2021.120363","volume":"598","author":"H Sadaquat","year":"2021","unstructured":"Sadaquat H, Akhtar M, Nazir M, Ahmad R, Alvi Z, Akhtar N. Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation. Int J Pharm. 2021;598:120363. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120363.","journal-title":"Int J Pharm"},{"key":"2603_CR29","doi-asserted-by":"publisher","first-page":"118523","DOI":"10.1016\/j.carbpol.2021.118523","volume":"273","author":"M Yusefi","year":"2021","unstructured":"Yusefi M, Lee-Kiun MS, Shameli K, Teow S-Y, Ali RR, Siew K-K, et al. 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment. Carbohydr Polym. 2021;273:118523. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118523.","journal-title":"Carbohydr Polym"},{"key":"2603_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.12.011","volume":"330","author":"YI Park","year":"2021","unstructured":"Park YI, Kwon S-H, Lee G, Motoyama K, Kim MW, Lin M, et al. pH-sensitive multi-drug liposomes targeting folate receptor \u03b2 for efficient treatment of non-small cell lung cancer. J Control Release. 2021;330:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.011.","journal-title":"J Control Release"},{"issue":"11","key":"2603_CR31","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1016\/j.xphs.2022.06.002","volume":"111","author":"SE Alavi","year":"2022","unstructured":"Alavi SE, Raza A, Esfahani MKM, Akbarzadeh A, Abdollahi SH, Shahmabadi HE. Carboplatin niosomal nanoplatform for potentiated chemotherapy. J Pharm Sci. 2022;111(11):3029\u201337. https:\/\/doi.org\/10.1016\/j.xphs.2022.06.002.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2603_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/10717544.2020.1754528","volume":"27","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Yang W, Ma F, Ma Q, Zhang B, Zhang Y, et al. Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis. Drug Deliv. 2020;27(1):691\u2013702. https:\/\/doi.org\/10.1080\/10717544.2020.1754528.","journal-title":"Drug Deliv"},{"key":"2603_CR33","doi-asserted-by":"publisher","first-page":"111774","DOI":"10.1016\/j.msec.2020.111774","volume":"121","author":"T Zwain","year":"2021","unstructured":"Zwain T, Alder JE, Sabagh B, Shaw A, Burrow AJ, Singh KK. Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3D BBB\/BBTB models. Mater Sci Eng C Mater Biol Appl. 2021;121:111774. https:\/\/doi.org\/10.1016\/j.msec.2020.111774.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"2603_CR34","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1021\/acs.molpharmaceut.5b00081","volume":"12","author":"G Fang","year":"2015","unstructured":"Fang G, Tang B, Chao Y, Xu H, Gou J, Zhang Y, et al. Cysteine-functionalized nanostructured lipid carriers for oral delivery of docetaxel: a permeability and pharmacokinetic study. Mol Pharm. 2015;12(7):2384\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00081.","journal-title":"Mol Pharm"},{"issue":"3","key":"2603_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/08982104.2012.662653","volume":"22","author":"J Varshosaz","year":"2012","unstructured":"Varshosaz J, Hassanzadeh F, Sadeghi H, Khadem M. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma. J Liposome Res. 2012;22(3):224\u201336. https:\/\/doi.org\/10.3109\/08982104.2012.662653.","journal-title":"J Liposome Res"},{"issue":"6","key":"2603_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1208\/s12249-021-02099-3","volume":"22","author":"K Borderwala","year":"2021","unstructured":"Borderwala K, Rathod S, Yadav S, Vyas B, Shah P. Eudragit S-100 surface engineered nanostructured lipid carriers for colon targeting of 5-fluorouracil: optimization and in vitro and in vivo characterization. AAPS PharmSciTech. 2021;22(6):216. https:\/\/doi.org\/10.1208\/s12249-021-02099-3.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2603_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/2277-9175.100147","volume":"1","author":"S Andalib","year":"2012","unstructured":"Andalib S, Varshosaz J, Hassanzadeh F, Sadeghi H. Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design. Adv Biomed Res. 2012;1(1):45. https:\/\/doi.org\/10.4103\/2277-9175.100147.","journal-title":"Adv Biomed Res"},{"issue":"7","key":"2603_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/pharmaceutics16070926","volume":"16","author":"A Chaudhuri","year":"2024","unstructured":"Chaudhuri A, Kumar DN, Srivastava SK, Kumar D, Patil UK, Parmar AS, et al. Combinatorial delivery of docetaxel-and erlotinib-loaded functionalized nanostructured lipid carriers for the treatment of triple-negative breast cancer using quality-by-design approach. Pharmaceutics. 2024;16(7):926. https:\/\/doi.org\/10.3390\/pharmaceutics16070926.","journal-title":"Pharmaceutics"},{"key":"2603_CR39","doi-asserted-by":"publisher","first-page":"106638","DOI":"10.1016\/j.ejps.2023.106638","volume":"192","author":"JS Passos","year":"2024","unstructured":"Passos JS, Apolinario AC, Ishida K, Martins TS, Lopes LB. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment. Eur J Pharm Sci. 2024;192:106638. https:\/\/doi.org\/10.1016\/j.ejps.2023.106638.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"2603_CR40","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","volume":"23","author":"J Qu","year":"2016","unstructured":"Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, et al. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Drug Deliv. 2016;23(9):3408\u201316. https:\/\/doi.org\/10.1080\/10717544.2016.1189465.","journal-title":"Drug Deliv"},{"key":"2603_CR41","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S166021","author":"SG Lee","year":"2018","unstructured":"Lee SG, Kim CH, Sung SW, Lee ES, Goh MS, Yoon HY, et al. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Int J Nanomed. 2018. https:\/\/doi.org\/10.2147\/IJN.S166021.","journal-title":"Int J Nanomed"},{"key":"2603_CR42","doi-asserted-by":"publisher","first-page":"213660","DOI":"10.1016\/j.bioadv.2023.213660","volume":"155","author":"T Zwain","year":"2023","unstructured":"Zwain T, Alder JE, Zwayen S, Shaw A, Burrow AJ, Singh KK. Overcoming biological barriers BBB\/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapy. Biomater Adv. 2023;155:213660. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213660.","journal-title":"Biomater Adv"},{"issue":"7","key":"2603_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/pharmaceutics16070960","volume":"16","author":"F-I Coco\u0219","year":"2024","unstructured":"Coco\u0219 F-I, Anu\u021ba V, Popa L, Ghica MV, Nica M-A, Mih\u0103il\u0103 M, et al. Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy. Pharmaceutics. 2024;16(7):960. https:\/\/doi.org\/10.3390\/pharmaceutics16070960.","journal-title":"Pharmaceutics"},{"issue":"23\u201324","key":"2603_CR44","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1557\/jmr.2020.227","volume":"35","author":"M Mao","year":"2020","unstructured":"Mao M, Liu S, Zhou Y, Wang G, Deng J, Tian L. Nanostructured lipid carrier delivering chlorins e6 as in situ dendritic cell vaccine for immunotherapy of gastric cancer. J Mater Res. 2020;35(23\u201324):3257\u201364. https:\/\/doi.org\/10.1557\/jmr.2020.227.","journal-title":"J Mater Res"},{"issue":"5","key":"2603_CR45","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1007\/s13277-014-1630-9","volume":"35","author":"H Ebrahimi Shahmabadi","year":"2014","unstructured":"Ebrahimi Shahmabadi H, Movahedi F, Koohi Moftakhari Esfahani M, Alavi SE, Eslamifar A, Mohammadi Anaraki G, et al. Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. Tumour Biol. 2014;35(5):4799\u2013806. https:\/\/doi.org\/10.1007\/s13277-014-1630-9.","journal-title":"Tumour Biol"},{"issue":"8","key":"2603_CR46","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.4314\/tjpr.v13i8.1","volume":"13","author":"MKM Esfahani","year":"2014","unstructured":"Esfahani MKM, Alavi SE, Akbarzadeh A, Ghassemi S, Saffari Z, Farahnak M, et al. Pegylation of nanoliposomal paclitaxel enhances its efficacy in breast cancer. Trop J Pharm Res. 2014;13(8):1195\u20138. https:\/\/doi.org\/10.4314\/tjpr.v13i8.1.","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"2603_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12291-013-0315-2","volume":"29","author":"SE Alavi","year":"2014","unstructured":"Alavi SE, Esfahani MKM, Ghassemi S, Akbarzadeh A, Hassanshahi G. In vitro evaluation of the efficacy of liposomal and pegylated liposomal hydroxyurea. Indian J Clin Biochem. 2014;29(1):84\u20138. https:\/\/doi.org\/10.1007\/s12291-013-0315-2.","journal-title":"Indian J Clin Biochem"},{"key":"2603_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-024-03722-1","author":"S Alharthi","year":"2024","unstructured":"Alharthi S, Alavi SZ, Nisa Mu, Koohi M, Raza A, Ebrahimi Shahmabadi H, et al. Developing engineered nano-immunopotentiators for the stimulation of dendritic cells and inhibition and prevention of melanoma. Pharm Res. 2024. https:\/\/doi.org\/10.1007\/s11095-024-03722-1.","journal-title":"Pharm Res"},{"key":"2603_CR49","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S233023","author":"Y Jian","year":"2020","unstructured":"Jian Y, Zhao M, Cao J, Fan T, Bu W, Yang Y, et al. A gastric cancer peptide GX1-modified nano-lipid carriers encapsulating paclitaxel: design and evaluation of anti-tumor activity. Drug Des Devel Ther. 2020. https:\/\/doi.org\/10.2147\/DDDT.S233023.","journal-title":"Drug Des Devel Ther"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02603-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:35:20Z","timestamp":1738208120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["2603"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02603-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}